Recent Faculty Publications

Lu H, Roeder N, Richardson B, Hamilton J, Sharma A, Owada Y, Kagawa Y, Thanos P. (2025) Fatty acid-binding protein 7 gene deletion promotes decreases in brain cannabinoid type 1 receptor binding. Neuroscience letters (Jan), 844: 138040.
Sharafshah A, Lewandrowski KU, Gold MS, Fuehrlein B, Ashford JW, Thanos PK, Wang GJ, Hanna C, Cadet JL, Gardner EL, Khalsa JH, Braverman ER, Baron D, Elman I, Dennen CA, Bowirrat A, Pinhasov A, Modestino EJ, Carney PR, Cortese R, Fiorelli RKA, Schmidt S, Pollack AR, Badgaiyan RD, Blum K. (2025) In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder. Current neuropharmacology (Jan).
Blum K, Bowirrat A, Thanos PK, Hanna C, Khalsa J, Baron D, Elman I, Badgaiyan RD, Dennen C, Braverman ER, Carney P, Lewandrowski KU, Sharafshah A, Gold MS. (2024) Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction. EC psychology and psychiatry (Dec), 13(1): 1-3.
Lewter LA, Woodhouse K, Tiruveedhula VVNPB, Cook JM, Li JX. (2024) Antinociceptive Effects of a2/a3-Subtype-Selective GABAA Receptor Positive Allosteric Modulators KRM-II-81 and NS16085 in Male Rats: Behavioral Specificity. The Journal of pharmacology and experimental therapeutics (Nov), 391(3): 389-398. doi:10.1124/jpet.123.002070
Costa PC, Salinas B, Wojciechowski A, Wood SK, Runyon S, Clark SD. (2024) The Influence of the Estrous Cycle on Neuropeptide S Receptor-Mediated Behaviors. The Journal of pharmacology and experimental therapeutics (Nov), 391(3): 460-471. doi:10.1124/jpet.124.002415
Martin MK, Rodriguez R, Guerrero G, Sheehan GD, Powell R, Klein AH, Bhattacharjee A. (2024) Pharmacologically enabling the degradation of NaV1.8 channels to reduce neuropathic pain. Pain (Nov).
Hrabak M, Ahmed R, Soriano MG, Powell A, Thanos PK, Steiner H. (2024) Correction: Vilazodone, a Novel SSRI Antidepressant with 5-HT1A Partial Agonist Properties: Diminished Potentiation of Chronic Oral Methylphenidate-Induced Dynorphin Expression in the Striatum in Adolescent Male Rats.
Peng L, Zhang J, Feng J, Ge J, Zou Y, Chen Y, Xu L, Zeng Y, Li JX, Liu J. (2024) Activation of trace amine-associated receptor 1 ameliorates PTSD-like symptoms. Biochemical pharmacology (Oct), 228: 116236.
Collins RL, Thanos PK, Ashare R, Herzberg D, Silverman R. (2024) Effects of the Federal Government's Move to Reschedule Cannabis: A Commentary. Journal of studies on alcohol and drugs (Oct).
Hrabak M, Ahmed R, Soriano MG, Powell A, Thanos PK, Steiner H. (2024) Vilazodone, a Novel SSRI Antidepressant with 5-HT1A Partial Agonist Properties: Diminished Potentiation of Chronic Oral Methylphenidate-Induced Dynorphin Expression in the Striatum in Adolescent Male Rats. Molecular neurobiology (Oct).
Penman SL, Roeder NM, Wang J, Richardson BJ, Pareek O, Freeman-Striegel L, Mohr P, Khan A, Eiden RD, Chakraborty S, Thanos PK. (2024) Vaporized nicotine in utero results in reduced birthweight, increased locomotion, and decreased voluntary exercise, dependent on sex and diet in offspring. Psychopharmacology (Sep), 241(9): 1857-1882.
Penman SL, Roeder NM, Wang J, Richardson BJ, Freeman-Striegel L, Krayevsky A, Eiden RD, Chakraborty S, Thanos PK. (2024) Vaporized ?9-tetrahydrocannabinol exposure in utero has negative effects on attention in a dose- and sex-dependent manner. Pharmacology, biochemistry, and behavior (Sep), 242: 173808.
Smith Z, Cheli VT, Angeliu CG, Wang C, Denaroso GE, Tumuluri SG, Corral J, Garbarini K, Paez PM. (2024) Ferritin loss in astrocytes reduces spinal cord oxidative stress and demyelination in the experimental autoimmune encephalomyelitis (EAE) model. Glia (Sep).
Blum K, Elman I, Han D, Hanna C, Baron D, Gupta A, Kazmi S, Khalsa J, Bagchi D, McLaughlin T, Badgaiyan RD, Modestino EJ, Edwards D, Dennen CA, Braverman ER, Bowirrat A, Sunder K, Murphy K, Jafari N, Zeine F, Carney PR, Gold MS, Lewandowski KU, Sharafshah A, Pollack AR, Thanos PK. (2024) The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies. Open journal of immunology (Sep), 14(3): 60-86. doi:10.4236/oji.2024.143006
Fisher C, Johnson K, Moore M, Sadrati A, Janecek JL, Graham ML, Klein AH. (2024) Loss of ATP-Sensitive Potassium Channel Expression and Function in the Nervous System Decreases Opioid Sensitivity in a High-Fat Diet-Fed Mouse Model of Diet-Induced Obesity. Diabetes (Aug), 73(8): 1244-1254. doi:10.2337/db23-1030
Nowak J, Aronin J, Beg F, O'Malley N, Ferrick M, Quattrin T, Pavlesen S, Hadjiargyrou M, Komatsu DE, Thanos PK. (2024) The Effects of Chronic Psychostimulant Administration on Bone Health: A Review. Biomedicines (Aug), 12(8). doi:10.3390/biomedicines12081914
Ortiz LM, O'Malley N, Blum K, Hadjiargyrou M, Komatsu DE, Thanos PK. (2024) Psychostimulants prescribed to children for ADHD following distal radius fractures significantly reduce bone density as a function of duration. Journal of pediatric orthopedics. Part B (Jul), 33(4): 399-406.
Khan A, Richardson B, Roeder N, Hamilton J, Marion M, Fearby N, White O, Owada Y, Kagawa Y, Thanos PK. (2024) The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling. Neuroscience letters (Jul), 836: 137862.
Blum K, Bowirrat A, Sunder K, Thanos PK, Hanna C, Gold MS, Dennen CA, Elman I, Murphy KT, Makale MT. (2024) Dopamine Dysregulation in Reward and Autism Spectrum Disorder. Brain sciences (Jul), 14(7). doi:10.3390/brainsci14070733
Roeder NM, Mihalkovic A, Richardson BJ, Penman SL, Novalen M, Hammond N, Eiden R, Khokhar JY, Tyndale RF, Thanos PK. (2024) Behavioral and Pharmacokinetic Assessment of Nicotine e-Cigarette Inhalation in Female Rats. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco (May), 26(6): 724-732. doi:10.1093/ntr/ntad240